Log in to save to my catalogue

Biomarkers of Barrett’s Esophagus: From the Laboratory to Clinical Practice

Biomarkers of Barrett’s Esophagus: From the Laboratory to Clinical Practice

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6054820

Biomarkers of Barrett’s Esophagus: From the Laboratory to Clinical Practice

About this item

Full title

Biomarkers of Barrett’s Esophagus: From the Laboratory to Clinical Practice

Publisher

New York: Springer US

Journal title

Digestive diseases and sciences, 2018-08, Vol.63 (8), p.2070-2080

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

The currently recommended approach to managing cancer risk for patients with Barrett’s esophagus is endoscopic surveillance including a biopsy protocol to sample the esophageal tissue randomly to detect dysplasia. However, there are numerous limitations in this practice that rely on the histopathological grading of dysplasia alone to make clinical...

Alternative Titles

Full title

Biomarkers of Barrett’s Esophagus: From the Laboratory to Clinical Practice

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6054820

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6054820

Other Identifiers

ISSN

0163-2116

E-ISSN

1573-2568

DOI

10.1007/s10620-018-5088-2

How to access this item